From: Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China
Presentations/No. of isolates | MAB (n = 10) | MAV (n = 10) | MKA (n = 5) | MIN (n = 61) | MGO (n = 1) | Total87 | Percent |
---|---|---|---|---|---|---|---|
Bronchiectasis | 7 | 2 | 4 | 20 | 1 | 34 | 39.1% |
Pulmonary Cavity | 6 | 2 | 2 | 23 | 0 | 33 | 37.9% |
Single cavity | 0 | 0 | 0 | 3 | 0 | 3 | 3.45% |
Multiple cavities | 6 | 2 | 2 | 20 | 0 | 30 | 34.48% |
Thick-walled cavity | 0 | 0 | 0 | 1 | 0 | 1 | 1.15% |
Thin-walled cavity | 6 | 2 | 2 | 22 | 0 | 32 | 36.78% |
Nodule | 5 | 4 | 2 | 22 | 0 | 33 | 37.9% |
Lymphadenovarix | 2 | 2 | 0 | 12 | 0 | 16 | 18.3% |
Pleural/Pericardial Effusion | 0 | 2 | 0 | 5 | 0 | 7 | 8.0% |
Destroyed lungs | 0 | 0 | 0 | 3 | 0 | 3 | 3.4% |
Pneumothorax | 0 | 0 | 1 | 1 | 0 | 2 | 2.3% |
Total Percent | 32 16.5% | 16 8.2% | 13 6.7% | 132 68% | 1 0.5% | 194 | Â |